Bactrim and FDA-approved generic sulfamethoxazole/trimethoprim products share the same pair of active ingredients when compared in corresponding formulations. The relevant pharmacy question is not whether the word “Bactrim” appears on both packages, but whether a specific generic matches the prescription and its reference product in active ingredients, strength, dosage form and applicable therapeutic-equivalence requirements.
Regular branded Bactrim tablets contain sulfamethoxazole 400 mg and trimethoprim 80 mg; Bactrim DS tablets contain 800 mg and 160 mg. Generics may be marketed for corresponding tablet strengths. However, a generic liquid is not a direct tablet substitute, and even two products with similar abbreviated names need professional verification before substitution.
This is a direct comparison of brand versus approved generic products. For generic naming, labelers and available forms without the head-to-head frame, read the generic TMP-SMX guide; for the named double-strength brand use Bactrim DS product information.
An approved generic can be supplied by a different labeler and have a different imprint, package count or price. A payer may put it on another formulary tier than the brand. None of those differences makes an unrelated oral suspension or different tablet strength automatically interchangeable with the written order.
The correct brand-versus-generic comparison holds the prescribed ingredient pair, component amounts, tablet dosage form and authorized quantity constant. The table highlights differences that a pharmacy may legitimately display, such as supplier, appearance and payment arrangements. FDA therapeutic-equivalence determinations and applicable state substitution rules govern the specific product decision; a generic oral liquid or differently sized tablet is not equivalent merely because it contains TMP-SMX.
| Attribute | Brand Bactrim | Matching approved generic |
|---|---|---|
| Name on pharmacy label | Bactrim or Bactrim DS | Sulfamethoxazole/trimethoprim |
| Active ingredients | Sulfamethoxazole plus trimethoprim | Same pair for corresponding formulation |
| Common tablets | 400/80 mg and 800/160 mg | Corresponding strengths as approved |
| Inactive ingredients / appearance | Brand-specific | May differ |
| Cost and coverage | Plan- and pharmacy-dependent | Plan- and pharmacy-dependent |
| Substitution decision | Prescriber and pharmacy rules apply | FDA equivalence and state rules apply |
The Orange Book provides an approved-drug reference and therapeutic-equivalence evaluations for applicable product listings. Matching ingredient amounts is an important step but should not replace a pharmacist’s review of the actual product and state substitution rules. A retail seller’s assertion of equivalence is not a substitute for FDA information.
A patient may recognize the brand from an earlier prescription or a search advertisement. Whether a brand-only order is appropriate is a clinical and coverage question. If the prescriber specifies a brand, the pharmacist should follow applicable law and clarify restrictions rather than silently substituting a different product.
The principal ingredient-related contraindications and serious warnings still apply, including hypersensitivity, severe skin reactions, hyperkalemia and interactions. Some inactive ingredients may differ between formulations, so patients with specific formulation allergies should review the dispensed product with the pharmacist.
A fair cost comparison matches the same authorized ingredient amounts, dosage form and required quantity, then checks brand or generic insurance treatment and the pharmacy’s final price. The branded DS versus generic price guide narrows this financial comparison to double-strength tablets.
Ask the pharmacist to read back the two active ingredients, strength, route and the approved product identifier. Confirm the printed prescription directions and ask for counseling. Do not decline or accept a medicine purely because its color, logo or packer name differs from an online photograph.
Corresponding approved generic products contain sulfamethoxazole and trimethoprim.
No. They differ in branding and may differ in inactive ingredients and appearance.
Applicable FDA therapeutic-equivalence information, prescription instructions and state law determine permitted substitution.
Not always for a given pharmacy and insurance plan; request a matched final quote.
No. The same active ingredients bring the relevant ingredient-related risks.
Not without appropriate clinical authorization and product verification.
No. It supplies approved-drug and equivalence information, not pharmacy inventory.